Correlation between progression-free and overall survival in a meta-analysis of aggregated survival data from patients with non-small cell lung cancer

被引：0
|
作者：
Aksenov, Sergey [1 ]
Lee, Daniel [2 ]
Edlund, Helena [1 ]
Minchella, Kaitlyn [1 ]
Xu, Hongmei [1 ]
Dunyak, James [1 ]
Al-Huniti, Nidal [1 ]
机构：
[1] AstraZeneca, Quantitat Clin Pharmacol, Waltham, MA USA
[2] Stan Grp, New York, NY USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
T-019
引用
收藏
页码：S63 / S64
页数：2
相关论文
共 50 条
  • [21] Correlations between overall response rate, progression-free survival and overall survival in refractory small cell lung cancer treated with lurbinectedin
    Wasifuddin, Mustafa
    Ilerhunmwuwa, Nosakhare Paul
    Hakobyan, Narek
    Tahir, Muhammad
    Abowali, Hesham
    Avezbakiyev, Boris
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer
    Masayuki Aboshi
    Masayuki Kaneko
    Mamoru Narukawa
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 839 - 848
  • [23] Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer
    Aboshi, Masayuki
    Kaneko, Masayuki
    Narukawa, Mamoru
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (05) : 839 - 848
  • [24] RELATIONSHIP OF PROGRESSION-FREE SURVIVAL, POST-PROGRESSION SURVIVAL AND RESPONSE WITH OVERALL SURVIVAL IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER OF INDIVIDUAL-LEVEL
    Imai, Hisao
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Shukuya, Takehito
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    RESPIROLOGY, 2013, 18 : 85 - 85
  • [25] An FDA analysis of the association of tumor growth rate and overall and progression-free survival in metastatic non-small cell lung cancer (NSCLC) patients.
    Gong, Yutao
    Mason, Jeremy
    Shen, Yuan-Li
    Chang, Elaine
    Kazandjian, Dickran
    Blumenthal, Gideon Michael
    Singh, Harpreet
    Theoret, Marc Robert
    Tang, Shenghui
    Pazdur, Richard
    Beaver, Julia A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] CORRELATION BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WITH OVARIAN CANCER AFTER DEBULKING SURGERY
    Chase, D.
    Mahajan, A.
    Scott, D. A.
    Hawkins, N.
    Woodward, T.
    Kalilani, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A286 - A286
  • [27] Association between event-free survival and overall survival after neoadjuvant treatment for non-small cell lung cancer: a systematic review and meta-analysis
    Ostoros, Gyula
    Hettle, Robert
    Georgoulia, Nefeli
    Berktas, Mehmet
    Chander, Pratibha
    Perez, Ignacio Diaz
    Couto, Anne-Marie
    Eichinger, Christian
    Field, Polly
    Morten, Peter
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (12) : 1305 - 1313
  • [28] Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab
    Taniguchi, Yoshihiko
    Tamiya, Akihiro
    Isa, Syun-Ichi
    Nakahama, Kenji
    Okishio, Kyoichi
    Shiroyama, Takayuki
    Suzuki, Hidekazu
    Inoue, Takako
    Tamiya, Motohiro
    Hirashima, Tomonori
    Imamura, Fumio
    Atagi, Shinji
    ANTICANCER RESEARCH, 2017, 37 (10) : 5857 - 5862
  • [29] Overall response rate as a surrogate of progression-free survival with molecular targeted agents: A meta-analysis of phase III trials in advanced non-small cell lung cancer.
    Akamatsu, Hiroaki
    Mori, Keita
    Kikuchi, Takashi
    Ueda, Hiroki
    Akamatsu, Keiichiro
    Nakanishi, Masanori
    Koh, Yasuhiro
    Matsunaga, Kazuto
    Yamamoto, Nobuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer
    Imai, Hisao
    Mori, Keita
    Wakuda, Kazushige
    Ono, Akira
    Akamatsu, Hiroaki
    Shukuya, Takehito
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    ANNALS OF THORACIC MEDICINE, 2015, 10 (01) : 61 - 66
12345